| Influence of intraperitoneal application of taurolidine on the perioperative metastases, tumor recurrence and survival rate after surgical resection of colorectal cancer | | ISRCTN43522674 |
| Assessment of TauroLock™ in port catheter | A comparison of the effect of taurolidine and 4 % citrate(TauroLock™-HEP500) and Heparin use in Port catheter on the function of catheter and prevention of catheter complications in children with malignancy | IRCT20201107049296N4 |
| Central Line-associated Bloodstream Infection Prevention Using TauroLock-Hep100 in Pediatric Oncology Patients. | The Efficacy of a Lock Solution Containing Taurolidine, Citrate and Heparin for the Prevention of Tunneled Central Line-associated Bloodstream Infections in Pediatric Oncology Patients, a Randomized Controlled, Mono-center Trial. | NCT05740150 |
| Taurolidine Containing Antimicrobial CIED Wash to Prevent Infection | Effect of Intraoperative Topical Application of a Taurolidine Solution on CIED Related Infections in the Clinical Setting - a Prospective Observational Study With a Restrospective Historical Control | NCT05576194 |
| A double-blind, placebo controlled randomised study to assess the tolerability, safety, and preliminary efficacy of taurolidine-citrate lock solution (TauroLock™) in patients with recurrent pleural effusions requiring management with Indwelling Pleural Catheters for recurrent effusion drainage. | A double-blind, placebo controlled randomised study to assess the tolerability, safety, and preliminary efficacy of taurolidine-citrate lock solution (TauroLock™) in patients with recurrent pleural effusions requiring management with Indwelling Pleural Catheters for recurrent effusion drainage. | ACTRN12622001280796 |
| Central Line-associated Bloodstream Infection Prevention Using TauroLock-Hep100 in Pediatric Oncology Patients | The Efficacy of a Lock Solution Containing Taurolidine, Citrate and Heparin for the Prevention of Tunneled Central Line-associated Bloodstream Infections in Pediatric Oncology Patients, a Randomized Controlled, Mono-center Trial. | NL-OMON20136 |
| Taurolock Hep 500 Versus Unfractionated Heparin as Anti-inflammatory in Hemodialysis Catheters. | Taurolidine Citrate and Unfractionated Heparin Combination Versus Unfractionated Heparin Alone in Prevention of Inflammation in Hemodialysis Catheters. | NCT03539718 |
| Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients. | Comparative effectiveness of catheter locking solutions with gentamicin/cefazolin versus taurolidine to reduce catheter-related infection in hemodialysis patients | RBR-6vfg7r |
| Antibiotic-lock technique with Taurolidine for prevention of central venous catheter infection in neutropenic patients | Antibiotic-lock technique with Taurolidine for prevention of central venous catheter infection in neutropenic patients: a randomized, double-blind, placebo-controlled study | ISRCTN47102251 |
| Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children | Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children With Intestinal Failure | NCT02515201 |
| Prevention of Dialysis Catheter Malfunction With Prophylactic Use of a Taurolidine Containing Urokinase | Prevention of Tunneled Cuffed Catheter Malfunction With Prophylactic Use of a Taurolidine Locking Solution Containing Urokinase : a Multicentric Randomized Controlled Trial | NCT02036255 |
| Taurolidine Lock in Long Term Parenteral Nutrition | The Value of Taurolidine Lock in Long Term Parenteral Nutrition | NCT02009189 |
| Study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurololidine-citrate and heparin catheter locks in patients treated with haemodialysis | Evaluating the need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurololidine-citrate and heparin catheter locks in patients treated with haemodialysis: An open-label, observational study with retrospective comparator groups | ISRCTN07668752 |
| Taurolidine in Haemodialysis Catheter Related Bacteraemia | A Randomised Controlled Trial of Taurolidine With Heparin for Prevention of Recurrence of Catheter Related Bacteraemia in Haemodialysis Patients. | NCT01243710 |
| Double-blind clinical trial of taurolidine-citrate for the prevention of infection in patients using tunnelled lines for haemodialysis | Taurolidine-citrate catheter locks for the prevention of bacteraemia in patients using tunnelled intravascular catheters for haemodialysis: a randomised double-blind controlled trial | ISRCTN51902376 |
| The anti-endotoxin agent, taurolidine, potentially reduces ischaemia-reperfusion injury through its metabolite taurine | An investigation into the efficacy of the anti-endotoxin agent, taurolidine in the attenuation of the post-reperfusion sequelae in patients subjected to cardio-pulmonary bypass: a double-blinded randomised clinical trial | ISRCTN58678663 |
| Using taurolidine to attenuate the surgically-induced endotoxaemia and the subsequent inflammatory response in patients with primary non-metastatic colon cancer | Using taurolidine to attenuate the surgically-induced endotoxaemia and the subsequent inflammatory response in patients with primary non-metastatic colon cancer | ISRCTN77829558 |
| Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | Phase I Trial of Taurolidine After Positive Second Look Surgery for Recurrent Ovarian Epithelial, Fallopian Tube and Primary Peritoneal Cancers | NCT00021034 |
| Taurolidine-citrate vs heparin as catheter lock solutions in paediatric patients | | ISRCTN86885538 |
| A randomised controlled trial comparing taurolidine-citrate with heparin for locking tunnelled haemodialysis catheters | | ISRCTN13630682 |
| The AOT (Acridine Orange and Taurolidine) Trial | The AOT (Acridine Orange and Taurolidine) Trial: a Survey on Diagnosis and Prevention of Catheter-Related Infections in Patients on Home Parenteral Nutrition | NCT00321165 |
| Intra-operative administration of taurolidine reduces level of interleukin-1 beta rather than povidone-iodine in patients with colon, gastric, and pancreatic cancer. A clinical prospective randomised multicenter trial. | | ISRCTN66478538 |
| Taurolidine in Treating Patients With Recurrent or Progressive Glioma | An Open-Label Dose-Ranging Study of the Safety of Taurolidine 2% Solution Administered Intravenously to Patients With Recurrent or Progressive High Grade Glioma | NCT00022360 |
| Effect of Taurolidin on Prevention of Bloodstream Infection | Prevention of Central Veinous Device Related Sepsis Relapse With Taurolidine in Patients on Parenteral Nutrition in Long-term Home | NCT00545831 |
